content: <HTML>
  <HEAD>
  <TITLE>Form 8-K - July 25, 2005</TITLE>
  </HEAD>
  <BODY>
  <CENTER><FONT SIZE=4><B>UNITED STATES <BR>SECURITIES AND EXCHANGE COMMISSION</B></FONT> <br>
  <FONT SIZE=3><B>WASHINGTON, D.C. 20549</B></FONT></CENTER>
  
  <H1 ALIGN=CENTER><FONT SIZE=4>FORM 8-K</FONT></H1>
  
  
  <CENTER><B>CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)<BR>
   OF THE SECURITIES EXCHANGE ACT OF 1934</B></CENTER>
  <br>
  <br>
  <CENTER><B>DATE OF REPORT:&nbsp;&nbsp;July 25, 2005</b></center>
  
  <br><center><b>Commission file number 1-8572</B></CENTER>
  <BR>
  <CENTER><FONT SIZE=4><B>TRIBUNE COMPANY</B></FONT> <br><FONT SIZE=3>(Exact
  name of registrant as specified in its charter)</FONT></CENTER>
  <BR>
  
  <table CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
    <tr>
      <td WIDTH="60%" VALIGN="TOP"><p ALIGN="CENTER"><B>Delaware</B><BR>(State or other
      jurisdiction of<BR>incorporation or organization)<P></td>
      <td WIDTH="40%" VALIGN="TOP"><p ALIGN="CENTER"><B>36-1880355</B><BR>
      (I.R.S. Employer<BR>
      Identification No.)<BR></td></tr>
  <TR VALIGN="BOTTOM">
       <TD ALIGN="LEFT"></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD></TR>
    <tr>
      <td WIDTH="60%" VALIGN="TOP"><p ALIGN="CENTER"><B>435 North Michigan Avenue<BR>
      Chicago, Illinois</B><BR>
      (Address of principal executive offices)<BR></td>
      <td WIDTH="40%" VALIGN="TOP"><p ALIGN="CENTER"><B>60611</B><BR>
      (Zip code)</td>
    </tr>
  </table>
  <BR>
  
  <CENTER>Registrant's telephone number, including area code:&nbsp;&nbsp;(312) 222-9100</CENTER>
  <br>
  
  
  <P>Check the appropriate box below if
  the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant
  under any of the following provisions:</p>
  
  
  
  <p>[&nbsp;&nbsp;]&nbsp;&nbsp; Written communication pursuant to
  Rule 425 under the Securities Act (17 CFR 230.425) </P>
  
  <p>[&nbsp;&nbsp;]&nbsp;&nbsp; Soliciting material pursuant to
  Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </P>
  
  <p>[&nbsp;&nbsp;]&nbsp;&nbsp; Pre-commencement communications pursuant to Rule
  14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </P>
  
  <p>[&nbsp;&nbsp;]&nbsp;&nbsp; Pre-commencement communications pursuant to
  Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </P>
  
  <HR>
  
  
  
  <!-- MARKER FORMAT-SHEET="Head Sub 2 Left" FSL="Default" -->
  <A NAME=A001></A>
  <H1 ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=3>ITEM 5.02.&nbsp;&nbsp;
  DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS;<BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL<BR>&nbsp;
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  OFFICERS.</FONT></H1>
  
  <!-- MARKER FORMAT-SHEET="Para Flush" FSL="Default" -->
  <P><FONT FACE="Times New Roman, Times, Serif" SIZE=3>On July 20, 2005, Miles D. White was
  elected as a member of the Board of Directors of Tribune Company, to serve in the class of
  directors with terms expiring at the Tribune Company 2007 Annual Meeting of Shareholders.
  Mr. White, 50, is chairman and chief executive officer of Abbott Laboratories, a
  broad-based medical products and pharmaceutical company based in north suburban Chicago. </FONT></P>
  
  <H1 ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=3>ITEM 5.03.&nbsp;&nbsp; AMENDMENTS TO
  ARTICLES OF INCORPORATION OR BY-<BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;LAWS; CHANGE IN FISCAL YEAR. </FONT></H1>
  
  <!-- MARKER FORMAT-SHEET="Para Flush" FSL="Default" -->
  <P><FONT FACE="Times New Roman, Times, Serif" SIZE=3>On July 20, 2005, the Board approved
  amendments to Section 3.9 of Article III of the Company&#146;s By-Laws in order to
  implement the Board&#146;s determination that the presiding non-management director be
  designated by the Board rather than be included as a duty of the Governance &amp;
  Compensation Committee chair. These amendments became effective July 20, 2005. The amended
  By-laws of the Company reflecting such amendments are filed with this report as Exhibit
  99. </FONT></P>
  
  <H1 ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=3>ITEM 9.01.&nbsp;&nbsp;
  FINANCIAL STATEMENTS AND EXHIBITS. </FONT></H1>
  
  <!-- MARKER FORMAT-SHEET="Para Flush" FSL="Default" -->
  <P><FONT FACE="Times New Roman, Times, Serif" SIZE=3>Exhibit 99 &#150; By-Laws of Tribune
  Company, as amended and in effect on July 20, 2005 </FONT></P>
  <BR>
  
  <H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=3>SIGNATURE </FONT></H1>
  
  <!-- MARKER FORMAT-SHEET="Para Flush" FSL="Default" -->
  <P><FONT FACE="Times New Roman, Times, Serif" SIZE=3>Pursuant to the requirements of the
  Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
  on its behalf by the undersigned hereunto duly authorized. </FONT></P>
  
  <br>
  <table CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
    <tr>
      <td WIDTH="40%" VALIGN="TOP"><p ALIGN="CENTER">&nbsp;<P></td>
      <td WIDTH="60%" VALIGN="TOP"><p ALIGN="LEFT">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TRIBUNE COMPANY<BR>&nbsp;&nbsp;&nbsp;&nbsp;
          (Registrant)<BR>&nbsp;<br>&nbsp;<br>&nbsp;</TD></tr>
    <tr>
      <td WIDTH="50%" VALIGN="TOP"><p ALIGN="left">Date:&nbsp;&nbsp;July 25, 2005 </td>
      <td WIDTH="50%" VALIGN="TOP"><p ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/&nbsp;&nbsp;Mark W. Hianik</u><br>&nbsp;&nbsp;&nbsp;
          &nbsp;&nbsp;Mark W. Hianik<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vice President</td>
    </tr>
  </table>
  
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "form8k072505.htm", "description": "FORM 8-K - JULY 25, 2005", "secsgml_size_bytes": 5624}]
metadata_filer: {"company-data": {"conformed-name": "TRIBUNE CO", "cik": "0000726513", "assigned-sic": "2711", "irs-number": "361880355", "state-of-incorporation": "DE", "fiscal-year-end": "1225"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-08572", "film-number": "05971995"}, "business-address": {"street1": "435 N MICHIGAN AVE", "street2": "STE 600", "city": "CHICAGO", "state": "IL", "zip": "60611", "phone": "3122229100"}}
text: Form 8-K - July 25, 2005
  UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  WASHINGTON, D.C. 20549
  FORM 8-K
  CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
  OF THE SECURITIES EXCHANGE ACT OF 1934
  DATE OF REPORT:  July 25, 2005
  Commission file number 1-8572
  TRIBUNE COMPANY
  (Exact
  name of registrant as specified in its charter)
  Delaware
  (State or other
      jurisdiction of
  incorporation or organization)
  36-1880355
  (I.R.S. Employer
  Identification No.)
  435 North Michigan Avenue
  Chicago, Illinois
  (Address of principal executive offices)
  60611
  (Zip code)
  Registrant's telephone number, including area code:  (312) 222-9100
  Check the appropriate box below if
  the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant
  under any of the following provisions:
  [  ]   Written communication pursuant to
  Rule 425 under the Securities Act (17 CFR 230.425)
  [  ]   Soliciting material pursuant to
  Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  [  ]   Pre-commencement communications pursuant to Rule
  14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [  ]   Pre-commencement communications pursuant to
  Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  ITEM 5.02.  
  DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS;
  ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL
  OFFICERS.
  On July 20, 2005, Miles D. White was
  elected as a member of the Board of Directors of Tribune Company, to serve in the class of
  directors with terms expiring at the Tribune Company 2007 Annual Meeting of Shareholders.
  Mr. White, 50, is chairman and chief executive officer of Abbott Laboratories, a
  broad-based medical products and pharmaceutical company based in north suburban Chicago.
  ITEM 5.03.   AMENDMENTS TO
  ARTICLES OF INCORPORATION OR BY-
  LAWS; CHANGE IN FISCAL YEAR.
  On July 20, 2005, the Board approved
  amendments to Section 3.9 of Article III of the Company's By-Laws in order to
  implement the Board's determination that the presiding non-management director be
  designated by the Board rather than be included as a duty of the Governance &
  Compensation Committee chair. These amendments became effective July 20, 2005. The amended
  By-laws of the Company reflecting such amendments are filed with this report as Exhibit
  99.
  ITEM 9.01.  
  FINANCIAL STATEMENTS AND EXHIBITS.
  Exhibit 99 – By-Laws of Tribune
  Company, as amended and in effect on July 20, 2005
  SIGNATURE
  Pursuant to the requirements of the
  Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
  on its behalf by the undersigned hereunto duly authorized.
  TRIBUNE COMPANY
  (Registrant)
  Date:  July 25, 2005
  /s/  Mark W. Hianik
  Mark W. Hianik
  Vice President